Beacon Capital Management LLC (Tennessee)’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Beacon Capital Management LLC (Tennessee)’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-20	Closed	-$1.57K	–	995
2022 Q4	$1.57K	Sell	20 -22	-52%	-$1.69K	﹤0.01%	831
2022 Q3	$3K	Hold	42	–	–	﹤0.01%	690
2022 Q2	$3K	Hold	42	–	–	﹤0.01%	735
2022 Q1	$3K	Buy	+42	New	+$3.26K	﹤0.01%	736

Other funds holding PJP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

Beacon Capital Management LLC (Tennessee)'s PJP Position: Q1 2023 in Review

Beacon Capital Management LLC (Tennessee) sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2023, closing a stake of 20 shares — an estimated $1.57K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in PJP in Q1 2022 and held it in 4 quarters. The position peaked at $3K in Q3 2022. 87 funds tracked by Wall St. Rank hold PJP as of Q1 2023.

Beacon Capital Management LLC (Tennessee) reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2023 after selling out during the quarter.
Beacon Capital Management LLC (Tennessee) sold 20 Invesco Pharmaceuticals ETF shares in Q1 2023, an estimated $1.57K.
Beacon Capital Management LLC (Tennessee) first reported a position in Invesco Pharmaceuticals ETF in Q1 2022 and held it in 4 quarters.
Beacon Capital Management LLC (Tennessee)'s Invesco Pharmaceuticals ETF position peaked at $3K in Q3 2022.
87 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2023.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q1 2023, filed 20 Apr 2023.